Stockreport

NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results

Nanobiotix S.A. - ADSs  (NBTX) 
PDF Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prol [Read more]